1A Anogenital Warts and All: STD Vaccines, EPT, and Disseminated Gonococcal Infections

Wednesday, September 21, 2016: 10:45 AM-12:00 PM
Room 204/205
Moderator:

10:45 AM
1A1
Prevalence of Anogenital Warts Among Participants in Private Health Plans in the United States, 2006-2014: Potential Impact of HPV Vaccination
Elaine W. Flagg, PhD, MS, Surveillance and Data Management Branch, Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA
11:05 AM
1A2
The Impact of Prescriptions on Sex Partner Treatment Using Expedited Partner Therapy for Chlamydia Trachomatis Infection, New York City, 2014-2015
Ashley Oliver, MPH, Bureau of Sexually Transmitted Disease Prevention and Control, New York City Department of Health and Mental Hygiene, Queens, NY, Julie Schillinger, MD, MSc, Bureau of Sexually Transmitted Disease Control, NYC Department of Health & Mental Hygiene, Division of Sexually Transmitted Disease Prevention, Centers for Disease Control and Prevention, Long Island City, NY and Ellen Klingler, MPH, Bureau of Sexually Transmitted Disease Control, New York City Department of Health & Mental Hygiene, Long Island City, NY
11:25 AM
1A3
Effectiveness of a Group B Omv Meningococcal Vaccine on Gonorrhoea in New Zealand – a Case Control Study
Helen Petousis-Harris, BSc, PhD1, Janine Paynter, BSc, MSc, PhD2, Jane Morgan, MBChB, MD3, Peter Saxton, PhD4, Jill Sherwood, MBChB, MPH5, Barbara McArdle, BHSc, MCE6, Felicity Goodyear-Smith, MBChB, MD, FRNZCGP2, Joanna Stewart, MSc7 and Steve Black, MD8, 1Department of General Practice and Primary Health Care, University of Auckland, Auckland, New Zealand, 2Department of General Practice and Primary Health Care, Univeristy of Auckland, Auckland, New Zealand, 3Waikato District Health Board, Waikato Sexual Health Clinic, Hamilton, New Zealand, 4Gay Men's Sexual Health, University of Auckland, Auckland, New Zealand, 5Health Science, Institute of Environmental Science and Research Ltd, Porirua, New Zealand, 6Department General Practice and Primary Health Care, University of Auckland, Auckland, New Zealand, 7Department of Biostatistics and Epidemiology, University of Auckland, Auckland, New Zealand, 8Department of Pediatrics,, University of Cincinnati Children’s Hospital, Ohio, OH
11:45 AM
1A4
Characterization of a Cluster of Disseminated Gonococcal Infections in One California County Using Clinical Data, Case Investigation, and Whole Genome Sequencing
Karen Scott, M.D.1, Varvara Kozyreva, Ph.D2, Vishnu Chaturvedi, Ph.D.2, James Beebe, PhD, D, (ABMM)3, Heidi Bauer, MD, MS, MPH4 and Julie Stoltey, MD, MPH4, 1Sexually Transmitted Disease Control Branch, California Department of Public Health, Richmond, CA, 2Microbial Disease Laboratory, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, Richmond, California, 3Public Health Laboratory, San Luis Obispo County Health Agency, San Luis Obispo, CA, 4STD Control Branch, California Department of Public Health, Richmond, CA
12:05 PM
1A5
Sentinel Pharmacy Surveillance for Expedited Partner Therapy Prescriptions in Neighborhoods Where Providers Regularly Write Expedited Partner Therapy Prescriptions, New York City, 2016
Ebiere Okah, BA1, Meighan Rogers, MPH2, Michelle Kim, Pharmacy Student Intern3, Vibhuti Arya, PharmD3 and Julia A. Schillinger, MD, Msc4, 1School of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, 2Bureau of STD Prevention and Control, New York City Department of Health and Mental Hygiene, LIC, NY, 3College of Pharmacy and Health Sciences, St. John's University, Queens, 4New York City Department of Health and Mental Hygiene, LIC, NY; Center for Disease Control and Prevention, Atlanta, Georgia
See more of: Oral and Poster